Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of a VEGF Inhibitor (Lucentis) in Refractory Macular Edema Due to Eales' Disease

NCT00384449 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00384449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00384449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of a VEGF Inhibitor (Lucentis) in Refractory Macular Edema Due to Eales' Disease
Lead sponsor
Oregon Health and Science University
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2006
Completion date
April 30, 2009
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eales' disease